The Effects of Pentoxifylline on PAI-1 in an Obese Population

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Obesity
Interventions
DRUG

Pentoxifylline

400mg PO TID x 8 weeks

DRUG

Placebo

PO TID x 8 weeks

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00770328 - The Effects of Pentoxifylline on PAI-1 in an Obese Population | Biotech Hunter | Biotech Hunter